CD34 and ductal breast carcinoma in situ: Taking into consideration the fact that, in DCIS-I and DCIS-H, the SMA positivity index was higher, while the CD34 positivity index was lower than the rest groups of study (Table 2), it was necessary to define whether this difference was of significance.